191 related articles for article (PubMed ID: 31374332)
1. Study characteristics impacted the pragmatism of randomized controlled trial published in nursing: a meta-epidemiological study.
Devos F; Foissac F; Bouazza N; Ancel PY; Tréluyer JM; Chappuy H
J Clin Epidemiol; 2019 Dec; 116():18-25. PubMed ID: 31374332
[TBL] [Abstract][Full Text] [Related]
2. The role of pragmatism in explaining heterogeneity in meta-analyses of randomised trials: a protocol for a cross-sectional methodological review.
Aves T; Allan KS; Lawson D; Nieuwlaat R; Beyene J; Mbuagbaw L
BMJ Open; 2017 Sep; 7(9):e017887. PubMed ID: 28871028
[TBL] [Abstract][Full Text] [Related]
3. Do randomized controlled nursing trials have a pragmatic or explanatory attitude? Findings from the Pragmatic-Explanatory Continuum Indicator Summary (PRECIS) tool exercise.
Palese A; Bevilacqua MG; Dante A;
J Nurs Res; 2014 Sep; 22(3):216-20. PubMed ID: 25111115
[TBL] [Abstract][Full Text] [Related]
4. Real-world evidence: How pragmatic are randomized controlled trials labeled as pragmatic?
Dal-Ré R; Janiaud P; Ioannidis JPA
BMC Med; 2018 Apr; 16(1):49. PubMed ID: 29615035
[TBL] [Abstract][Full Text] [Related]
5. Trends in the Explanatory or Pragmatic Nature of Cardiovascular Clinical Trials Over 2 Decades.
Sepehrvand N; Alemayehu W; Das D; Gupta AK; Gouda P; Ghimire A; Du AX; Hatami S; Babadagli HE; Verma S; Kashour Z; Ezekowitz JA
JAMA Cardiol; 2019 Nov; 4(11):1122-1128. PubMed ID: 31473763
[TBL] [Abstract][Full Text] [Related]
6. Are trials of psychological and psychosocial interventions for schizophrenia and psychosis included in the NICE guidelines pragmatic? A systematic review.
Gastaldon C; Mosler F; Toner S; Tedeschi F; Bird VJ; Barbui C; Priebe S
PLoS One; 2019; 14(9):e0222891. PubMed ID: 31550279
[TBL] [Abstract][Full Text] [Related]
7. The PRECIS-2 tool seems not to be useful to discriminate the degree of pragmatism of medicine masked trials from that of open-label trials.
Dal-Ré R
Eur J Clin Pharmacol; 2021 Apr; 77(4):539-546. PubMed ID: 33106910
[TBL] [Abstract][Full Text] [Related]
8. A comparison of meta-analytic methods for synthesizing evidence from explanatory and pragmatic trials.
Sajobi TT; Li G; Awosoga O; Wang M; Menon BK; Hill MD; Thabane L
Syst Rev; 2018 Jan; 7(1):19. PubMed ID: 29370830
[TBL] [Abstract][Full Text] [Related]
9. A dynamic application of PRECIS-2 to evaluate implementation in a pragmatic, cluster randomized clinical trial in two nursing home systems.
Palmer JA; Mor V; Volandes AE; McCreedy E; Loomer L; Carter P; Dvorchak F; Mitchell SL
Trials; 2018 Aug; 19(1):453. PubMed ID: 30134976
[TBL] [Abstract][Full Text] [Related]
10. Systematic Review of the "Pragmatism" of Pragmatic Critical Care Trials.
Palakshappa JA; Gibbs KW; Lannan MT; Cranford AR; Taylor SP
Crit Care Explor; 2022 Jul; 4(7):e0738. PubMed ID: 35923590
[TBL] [Abstract][Full Text] [Related]
11. Using the Pragmatic-Explanatory Continuum Indicator Summary (PRECIS) model in clinical research: Application to refine a practice-based research network (PBRN) study.
Elder WG; Munk N
J Am Board Fam Med; 2014; 27(6):846-54. PubMed ID: 25381083
[TBL] [Abstract][Full Text] [Related]
12. Generalizability of randomized controlled trials in primary health care: Applying the PRECIS-2 tool on published protocols.
Papagiannopoulou E; Laiou E; Tatsi C; Dimakopoulos G; Ntzani EE; Siamopoulos K; Tatsioni A
J Eval Clin Pract; 2023 Mar; 29(2):253-262. PubMed ID: 36072984
[TBL] [Abstract][Full Text] [Related]
13. Meta-research on pragmatism of randomized trials: rationale and design of the PragMeta database.
Hirt J; Janiaud P; Düblin P; Hemkens LG
Trials; 2023 Jun; 24(1):437. PubMed ID: 37391755
[TBL] [Abstract][Full Text] [Related]
14. Framing the conversation: use of PRECIS-2 ratings to advance understanding of pragmatic trial design domains.
Lipman PD; Loudon K; Dluzak L; Moloney R; Messner D; Stoney CM
Trials; 2017 Nov; 18(1):532. PubMed ID: 29126437
[TBL] [Abstract][Full Text] [Related]
15. PRECIS-2 analysis of pragmatic acupuncture trials: a systematic review.
Lim J; Lee H; Kim YS
BMC Complement Med Ther; 2024 May; 24(1):181. PubMed ID: 38702632
[TBL] [Abstract][Full Text] [Related]
16. Making clinical trials more relevant: improving and validating the PRECIS tool for matching trial design decisions to trial purpose.
Loudon K; Zwarenstein M; Sullivan F; Donnan P; Treweek S
Trials; 2013 Apr; 14():115. PubMed ID: 23782862
[TBL] [Abstract][Full Text] [Related]
17. The PRECIS-2 tool has good interrater reliability and modest discriminant validity.
Loudon K; Zwarenstein M; Sullivan FM; Donnan PT; Gágyor I; Hobbelen HJSM; Althabe F; Krishnan JA; Treweek S
J Clin Epidemiol; 2017 Aug; 88():113-121. PubMed ID: 28603007
[TBL] [Abstract][Full Text] [Related]
18. How pragmatic are randomized trials of remdesivir and favipiravir for in-hospital treatment of COVID-19: a descriptive methodological review of trial design using the PRECIS-2 framework.
Sharma T; Qamar I; Zwarenstein M
J Clin Epidemiol; 2022 Dec; 152():193-200. PubMed ID: 36265553
[TBL] [Abstract][Full Text] [Related]
19. Analysis of the characteristics and the degree of pragmatism exhibited by pragmatic-labelled trials of antineoplastic treatments.
Saesen R; Depreytere K; Krupianskaya K; Langeweg J; Verheecke J; Lacombe D; Huys I
BMC Med Res Methodol; 2023 Jun; 23(1):148. PubMed ID: 37355603
[TBL] [Abstract][Full Text] [Related]
20. Randomized controlled trials and neurosurgery: the ideal fit or should alternative methodologies be considered?
Mansouri A; Cooper B; Shin SM; Kondziolka D
J Neurosurg; 2016 Feb; 124(2):558-68. PubMed ID: 26315006
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
